New drug cocktail aims to keep aggressive lung cancer at bay
NCT ID NCT07376499
Summary
This study is testing a combination of four drugs to see if they can help control extensive-stage small cell lung cancer after initial chemotherapy. The treatment involves intravenous infusions and daily pills, and patients continue taking some drugs long-term to try to delay the cancer's return. Researchers will measure how long patients live without their cancer getting worse and monitor side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SMALL CELL LUNG CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.